GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 12/06/2009
PIL Anectine Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/06/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to information about driving or using machinery
Updated on 26/01/2009 and displayed until 12/06/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 28/04/2008 and displayed until 26/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 05/02/2008 and displayed until 28/04/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change from BAN to rINN
  • Change to drug interactions
  • Change to side-effects
Updated on 16/02/2004 and displayed until 05/02/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 10/04/2003 and displayed until 16/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 01/08/2002 and displayed until 10/04/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 01/08/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 24/11/2000 and displayed until 08/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   suxamethonium chloride